Skip to main content

Febrile Neutropenia News

FDA Approves Fulphila (pegfilgrastim-jmdb), the First Biosimilar to Neulasta

HERTFORDSHIRE, England and PITTSBURGH and BENGALURU, India, June 4, 2018 /PRNewswire/ – Mylan N.V. (NASDAQ: MYL) and Biocon Ltd. (BSE code: 532523, NSE: BIOCON) today announced that the U.S. Food...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related drug support groups

Cipro, ciprofloxacin, Augmentin, vancomycin, Neulasta, amoxicillin / clavulanate, pegfilgrastim